IOL Chemicals secures patent for invention related to preparation of Sartan drugs
27 Nov 2022 //
BUSINESS-STANDARD
China Pharma`s Candesartan Hypertension Product Passes Bioequivalence Tests
05 Aug 2021 //
PRNEWSWIRE
Candesartan Is Associated With Lower Amyloid Accumulation
26 Jul 2021 //
FIRSTWORDPHARMA
Candesartan Is Associated With Lower Amyloid Accumulation
26 Jul 2021 //
FIRSTWORDPHARMA
TGA investigation - potential contamination with N-nitroso compounds
26 Feb 2019 //
TGA
Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)
04 Feb 2019 //
EDQM